Trial intelligence / Profile preview

OM-85 BV for Recurrent Wheezing in Children

NCT00733226Phase 4Completed

Sponsor
Keçiören Eğitim ve Araştırma Hastanesi
Start
Aug 2007
Primary completion
Sep 2008
Modality
Microbiome Therapeutics, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of OM-85 in asthma, wheeze, sponsored by Keçiören Eğitim ve Araştırma Hastanesi. Started Aug 2007; status: completed.

02

Drugs

OM-85
03

Conditions

asthmawheeze

Beyond the preview

Go deeper on NCT00733226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00733226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call